<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03695640</url>
  </required_header>
  <id_info>
    <org_study_id>MgTKA</org_study_id>
    <nct_id>NCT03695640</nct_id>
  </id_info>
  <brief_title>Effect of Magnesium Sulphate on Analgesia Following Knee Arthroplasty</brief_title>
  <official_title>The Effect of Magnesium Sulfate Added to Levobupivacaine in Continous Femoral Block on Analgesic Requirements Following Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ufuk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ufuk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to investigate the effect of magnesium sulfate added to
      levobupivacaine in continuous femoral nerve block following total knee arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain after knee arthroplasty is a serious concern. This study was designed to investigate the
      effect of magnesium sulfate added to levobupivacaine in continuous femoral nerve block on
      analgesic requirements following total knee arthroplasty.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2018</start_date>
  <completion_date type="Anticipated">December 15, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized, controlled, prospective</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Score</measure>
    <time_frame>T0:(Baseline) Postoperative 1st hour, T1: Change in 2nd, T2: Change in 4th, T3: Change in 6th, T4: Change in 12th, T5: Change in 24th, T6: Change in 36th, T7: Change in 48th, T8: Change in 72nd hours</time_frame>
    <description>measurement of postoperative pain using Visual Analogue Score. Minimum: 0 Maximum: 10. Higher values represent more pain, hence lower values are better</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analgesic consumption</measure>
    <time_frame>T0:(Baseline) Postoperative 1st hour, T1: Change in 2nd, T2: Change in 4th, T3: Change in 6th, T4: Change in 12th, T5: Change in 24th, T6: Change in 36th, T7: Change in 48th, T8: Change in 72nd hours</time_frame>
    <description>Consumption of local anesthetic in patient controlled analgesia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Knee Arthroplasty, Total</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Group L</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>continuous femoral nerve block with levobupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group LM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>continuous femoral nerve block with levobupivacaine and magnesium sulfate</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>Addition of magnesium sulfate as an adjuvant to levobupivacaine</description>
    <arm_group_label>Group LM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>continuous femoral nerve block</intervention_name>
    <description>continuous nerve block with levobupivacaine for treatment postoperative pain</description>
    <arm_group_label>Group L</arm_group_label>
    <arm_group_label>Group LM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled for elective unilateral primary total knee arthroplasty

        Exclusion Criteria:

          -  Patient refusal to enroll in the study

          -  Patient refusal of neuraxial anesthesia

          -  Existence of contraindications for neuraxial anesthesia

          -  Known history of allergy to any of the study drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Baturay K Kazbek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UFUK UNIVERSITY FACULTY OF MEDICINE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Baturay K Kazbek, MD</last_name>
    <phone>+903122044000</phone>
    <phone_ext>4098</phone_ext>
    <email>bkkazbek@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ufuk University Faculty of Medicine Hospital</name>
      <address>
        <city>Ankara</city>
        <state>Balgat</state>
        <zip>06510</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Baturay K Kazbek, MD</last_name>
      <phone>+903122044000</phone>
      <phone_ext>4098</phone_ext>
      <email>bkkazbek@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Albrecht E, Morfey D, Chan V, Gandhi R, Koshkin A, Chin KJ, Robinson S, Frascarolo P, Brull R. Single-injection or continuous femoral nerve block for total knee arthroplasty? Clin Orthop Relat Res. 2014 May;472(5):1384-93. doi: 10.1007/s11999-013-3192-3.</citation>
    <PMID>23928707</PMID>
  </reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 2, 2018</study_first_submitted>
  <study_first_submitted_qc>October 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2018</study_first_posted>
  <last_update_submitted>October 3, 2018</last_update_submitted>
  <last_update_submitted_qc>October 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ufuk University</investigator_affiliation>
    <investigator_full_name>Baturay Kansu Kazbek</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>total knee arthroplasty</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>continuous femoral nerve block</keyword>
  <keyword>magnesium sulphate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

